ASTRAZEN - Swing Trade Analysis with AI Signals
Back to List📊 Swing Trade Rating: 2.8
| Stock Code | ASTRAZEN | Market Cap | 20,105 Cr. | Current Price | 8,046 ₹ | High / Low | 10,691 ₹ |
| Stock P/E | 96.6 | Book Value | 320 ₹ | Dividend Yield | 0.40 % | ROCE | 33.4 % |
| ROE | 23.6 % | Face Value | 2.00 ₹ | DMA 50 | 8,425 ₹ | DMA 200 | 8,565 ₹ |
| Chg in FII Hold | 0.07 % | Chg in DII Hold | 0.24 % | PAT Qtr | 31.6 Cr. | PAT Prev Qtr | 58.1 Cr. |
| RSI | 38.6 | MACD | -16.4 | Volume | 12,282 | Avg Vol 1Wk | 8,694 |
| Low price | 7,552 ₹ | High price | 10,691 ₹ | PEG Ratio | 2.23 | Debt to equity | 0.04 |
| 52w Index | 15.8 % | Qtr Profit Var | -42.3 % | EPS | 80.4 ₹ | Industry PE | 30.2 |
Analysis: ASTRAZEN currently trades at ₹8,046, below both 50 DMA (₹8,425) and 200 DMA (₹8,565), reflecting weak technical momentum. RSI at 38.6 indicates oversold conditions but not yet a strong reversal. MACD is negative, confirming bearish sentiment. Valuation is stretched with a P/E of 96.6 compared to industry average of 30.2. Quarterly profit dropped significantly (-42.3%), which adds risk for swing traders.
Optimal Entry: A safer entry would be near the support zone of ₹7,550–7,600.
Exit Strategy: If already holding, consider exiting around resistance levels ₹8,400–8,600 unless momentum indicators improve.
✅ Positive
- Strong ROCE (33.4%) and ROE (23.6%) indicate efficient capital use.
- Low debt-to-equity ratio (0.04) shows financial stability.
- Institutional interest with slight increase in FII and DII holdings.
⚠️ Limitation
- High valuation compared to peers (P/E 96.6 vs industry 30.2).
- Weak technical indicators (below DMA, negative MACD).
- Low dividend yield (0.40%) offers limited income support.
📉 Company Negative News
- Quarterly profit fell sharply (-42.3%).
- EPS growth not aligned with high valuation.
📈 Company Positive News
- Strong fundamentals with high ROCE and ROE.
- Minimal debt ensures balance sheet strength.
🏭 Industry
- Industry P/E is 30.2, much lower than ASTRAZEN’s 96.6.
- Sector growth is steady but valuations are more moderate compared to peers.
📝 Conclusion
ASTRAZEN is fundamentally strong but technically weak and overvalued. It is not an ideal swing trade candidate unless price approaches strong support near ₹7,550. Holders should consider exiting near ₹8,400–8,600 unless momentum improves.